Squarepoint’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-41,326
| Closed | -$328K | – | 2828 |
|
|
2025
Q1 | $328K | Buy |
41,326
+11,297
| +38% | +$89.6K | ﹤0.01% | 2147 |
|
|
2024
Q4 | $380K | Buy |
+30,029
| New | +$380K | ﹤0.01% | 2077 |
|
|
2024
Q3 | – | Sell |
-186,484
| Closed | -$2.57M | – | 2633 |
|
|
2024
Q2 | $2.57M | Buy |
+186,484
| New | +$2.57M | ﹤0.01% | 956 |
|
|
2024
Q1 | – | Sell |
-15,927
| Closed | -$233K | – | 2535 |
|
|
2023
Q4 | $233K | Sell |
15,927
-30,917
| -66% | -$451K | ﹤0.01% | 2066 |
|
|
2023
Q3 | $575K | Sell |
46,844
-114,942
| -71% | -$1.41M | ﹤0.01% | 1553 |
|
|
2023
Q2 | $1.93M | Sell |
161,786
-62,191
| -28% | -$743K | 0.01% | 911 |
|
|
2023
Q1 | $2.99M | Buy |
223,977
+193,161
| +627% | +$2.58M | 0.01% | 675 |
|
|
2022
Q4 | $663K | Buy |
+30,816
| New | +$663K | ﹤0.01% | 1320 |
|
|
2021
Q3 | – | Sell |
-18,927
| Closed | -$431K | – | 2331 |
|
|
2021
Q2 | $431K | Buy |
+18,927
| New | +$431K | ﹤0.01% | 1713 |
|